Antisecretory and ulcer healing effects of S-0509, a novel CCK-B/gastrin receptor antagonist, in rats

Digestive Diseases and Sciences

Volumn 44, Issue 5, 1999, Pages 879-888

  Amagase, Kikuko ^a   Ikeda, Kyoko ^a   Okabe, Susumu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

CCK B gastrin receptor antagonist; Famotidine; Gastric acid secretion; S 0509

Indexed keywords

CARBACHOL; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; FAMOTIDINE; GASTRIN ANTAGONIST; HISTAMINE; INDOMETACIN; PENTAGASTRIN; S 0509; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIVITY; DRUG STRUCTURE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; STOMACH ULCER; TREATMENT OUTCOME; ULCER HEALING;

ANIMALS; BENZOPHENONES; FAMOTIDINE; GASTRIC ACID; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; PHENYLUREA COMPOUNDS; RATS; RATS, INBRED STRAINS; RECEPTORS, CHOLECYSTOKININ; STOMACH ULCER; WOUND HEALING;

EID: 0032933268     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026631808011     Document Type: Article

References (34)

1. Isenberg JI, McQuaid KR, Laine L, Walsh JH: Therapy for ulcer disease. In Textbook of Gastroenterology. T Yamada (eds). Philadelphia, Lippincott, 1995, pp 1378-1389
2. Hirschowitz BI, Keeling D, Lewin M, Okabe S, Parsons M, Sewing K, Wallmark B, Sachs G: Pharmacological aspects of acid secretion. Dig Dis Sci 40:3S-23S, 1995
3. Graham DY, Colon-Pagan J, Morse RS, Johnson TL, Walsh JH, McCullough AJ, Marks JW, Sklar M, Stone RC, Cagliola AJ, Walton-Bowen KL, Humphries TJ: The Omeprazple Duodenal Ulcer Study Group: Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: A double-blind, multicenter, 6-month study. Gastroenterology 102:1289-1294, 1992
4. Eckman L, Hansson E, Havu N, Carlsson E, Lundberg C: Toxicological studies on omeprazole. Scand J Gastroenterol 20(suppl 108):53-69, 1985
5. 2 blockade and gastric carcinoid tumors in the rat. Gut 26:1284-1295, 1985
6. Axelson J, Hakanson R, Rosengren E, Sundler F: Hypergastrinemia induced by acid blockade evokes enterochromaffin like (ECL) cell hyperplasia in chicken, hamster and guinea pig stomach. Cell Tissue Res 105:15-21, 1988
7. Wallmark B, Skanberg I, Mattson H, Andersson K, Sundler F, Hakanson R, Carlsson E: Effects of 20 weeks ranitidine treatment on plasma gastrin levels and gastric enterochromaffin-like cell density in the rat. Digestion 45:181-188, 1990
8. Li H, Helander HF: Hypergastrinemia increases proliferation of gastroduodenal epithelium during gastric ulcer healing in rats. Dig Dis Sci 41:40-48, 1996
9. 2 receptor antagonist and proton pump inhibitor. Dig Dis Sci 43:253-257, 1998
10. Lotti VJ, Chang RSL: A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol 162:273-280, 1989
11. Hirst BH, Ellioit K, Ryder H, Szelke M: Inhibition of gastrinand histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat. Aliment Pharmacol Ther 5:31-39, 1991
12. Charles EP, Leo RF, Richard WE, Bruce FM, Gregory EM: The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat. J Pharmacol Exp Ther 265:1348-1354, 1993
13. Horwell DC, Hughes J, Hunter JC, Pritchard MC, Richardson RS, Roberts E, Woodruff GN: Rationally designed dioeptoid analogues of CCK. α-methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties. J Med Chem 34:404-414, 1991
14. Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, Kamato T, Ito H, Yamano M, Katuyama Y, Satoh M, Ohta M, Honda K: Pharmacological profile of (R)-1-[2,3-dihydro-1-(2′-methyl-phenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiaze pin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo. J Pharmacol Exp Ther 269:725-731, 1994
15. Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamato T, Ito H, Yamano M, Nagakura Y, Miyata K: YM022 {(R)-1-[2,3-dihydro-1-(2′-methyl-phenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiaz epin-3-yl]-3-(3-methylphenyl)urea}, a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats. J Pharmacol Exp Ther 270:1256-1261, 1994
16. Nishida A, Kobayashi-Uchida A, Akuzawa S, Takinami Y, Shishido T, Kamato T, Ito H, Yamano M, Yuki H, Nagakura Y, Honda K, Miyata K: Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression. Am J Physiol 269:G699-G705, 1995
17. Hagishita S, Murakami Y, Seno K, Kamata S, Haga N, Konoike T, Kanda Y, Kiyama R, Shiota T, Ishihara Y, Ishikawa M, Shimamura M, Abe K, Yoshimura K: Synthesis and pharmacological properties of ureidomethylcarbamoylphenylketone derivatives. A new potent and subtype-selective non-peptide CCK-B gastrin receptor antagonist, S-0509. Bio Med Chem 5:1695-1714, 1997
18. Konturek SJ, Brzozowski T, Piastucki I, Radecki T, Dembinski A, Dembinska-Kiec A: Role of locally generated prostaglandins in adaptive gastric cytoprotection. Dig Dis Sci 27:967-971, 1982
19. Tsukimi Y, Okabe S: Validity of kissing gastric ulcers induced in rats for screening of antiulcer drugs. J Gastroenterol Hepatol 9:S60-S65, 1994
20. Tsukimi Y, Okabe S: Effect of anterior unilateral vagotomy on healing of kissing gastric ulcers induced in rats. Jpn J Pharmacol 66:105-114, 1994
21. Tsukimi Y, Nozue C, Okabe S: Effects of leminoprazole, omeprazole and sucralfate on indomethacin-induced delayed healing of kissing gastric ulcers in rats. J Gastroenterol Hepatol 11:335-340, 1996
22. Wang JY, Yamasaki S, Takeuchi K, Okabe S: Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology 96:393-402, 1989
23. Larsson H, Carlsson E, Junggren U, Olbe L, Sjostrand E, Skanberg I, Sundell G: Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 85:900-907, 1983
24. Okabe S, Takagi K, Inoue K: Effect of NC-1300-03 on healing of acetic acid-induced gastric ulcers in rats. Jpn J Pharmacol 62:25-33, 1993
25. Harty RF, Maico DG, McGuigan JE: Comparison of adrenergic and cholinergic receptor-mediated stimulation of gastrin release from rat antral fragments. Peptides 9:463-468, 1988
26. Koop I, Squires PE, Meloche RM, Buchan AM: Effect of cholinergic agonists on gastrin release from primary cultures of human antral G cells. Gastroenterology 112:357-363, 1997
27. Nishida A, Yuki H, Tsutsumi R, Miyata K, Kamato T, Ito H, Yamano M, Honda K: L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats. Jpn J Pharmacol 58:137-145, 1992
28. Nishida A, Kobayashi-Uchida A, Takemoto Y, Akuzawa S, Miyata K: Comparative evaluation of the role of endogenous gastrin in basal acid secretion in conscious fistula rats and pylorus-ligated rats. Jpn J Pharmacol 71:223-230, 1996
29. Okabe S, Nozue C, Amagase K: Mechanism by which omeprazole and leminoprazole enhance healing of acetic acid gastric ulcers in rats: Role of circulating gastrin. In Gastroduodenal Mucosal Damage: Problems of Protection and Healing. R Cheli, G Iaquinto, S Szabo (eds). Naples, Mediserve, 1997, pp 169-182
30. Takagi K, Okabe S, Saziki R: A new method for the production of chronic gastric ulcers in rats and the effects of several drugs on their healing. Jpn J Pharmacol 69:418-426, 1969
31. Lee H, Hansson HA, Norstrom E, Helander HF: Immunoreactivities for epidermal growth factor (EGF) and for EGF receptors in rats with gastric ulcers. Cell Tissue Res 265:211-218, 1991
32. Keto S, Takahashi S, Okabe S. Healing of Heliocobacter pylori-induced gastric ulcers in mongolian gerbils: Combined treatment with omeprazole and clarithromycin. Dig Dis Sci (in press)
33. Cardiot G, Lehy T, Bonfils S: Action of somatostatin analogue (SMS201-995) on the growth promoting effect resulting from sustained achlorhydria in rat gastric mucosa, with special reference to endocrine cell behavior. Eur J Clin Invest 18:360-368, 1988
34. Meijer JL, Jansen JBMJ, Crobach LFSJ, Biemond K, Lamers CBHW: Inhibition of omeprazole-induced hypergastrinemia by SMS 201-995, a long-acting somatostatin analogue in man. Gut 34:1186-1190, 1993